AXP vs RPRX · P/E 20, rev $21.73B vs P/E 15, rev $1.30B
American Express Company (AXP) versus Royalty Pharma Plc (RPRX) — a side-by-side from cached financials, not a winner call.
American Express Company (AXP) is a credit services company listed on US. It is led by Stephen Joseph Squeri.
Royalty Pharma Plc (RPRX) is a biotechnology company listed on US.
Latest reported AXP revenue for 2026-06-30 was $21.73B. Net income was $6.08B. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
Latest reported RPRX revenue for 2026-06-30 was $1.30B. Net income was $312.6M. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
AXP currently screens at market cap $215.94B and trailing P/E 19.8. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
Not investment advice. Open the AXP and RPRX stock pages for the full models.
Not investment advice.